Brief: Mateon Therapeutics Q2 loss per share $0.14
03/08/2016 13:00
Aug 3 (Reuters) - Mateon Therapeutics Inc MATN.O
* Mateon provides corporate update and reports second
quarter 2016 financial results
* Qtrly loss per share $0.14
Source text for Eikon: ID:nGNXMZEMJa
Further company coverage: MATN.O
(Bengaluru Newsroom: +1 646 223 8780)
Recent news on Oncotelic Therapeutics
See all newsBrief: Oncotelic Therapeutics Emerging As Leader With New Independent JV Valuation
Brief: Oncotelic Therapeutics - JV Is Preparing For A Potential Initial Public Offering On The Hong Kong Stock Exchange In Late 2026
Brief: Oncotelic Therapeutics To Sell Its Necroptosis Cancer Therapy Assets To Mosaic Immunoengineering
Brief: Oncotelic Announces Initiation Of Clinical Study In Non-Small Lung Cell Cancer
Brief: Oncotelic Initiates Clinical Trials Evaluating Ot-101 Against Pediatric Gliomas